Dextromethorphan and an oxidase inhibitor for treating intractable conditions
US5863927A · kind A · utility
36Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 1996 |
| Grant date | Jan 26, 1999 |
| Priority date | — |
| Expiry date | Sep 19, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction comprising administering dextromethorphan in combination with a therapeutically effective dosage of a debrisoquin hydroxylase inhibitor. A preferred combination is dextromethorphan and the oxidative inhibitor quinidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.